- Section 1 Patients and their treatment
- Section 2 Background to medicine
- Section 3 Cell biology
- Section 4 Immunological mechanisms
- Section 5 Principles of clinical oncology
- Section 6 Old age medicine
- Section 7 Pain and palliative care
- Section 8 Infectious diseases
- Section 9 Sexually transmitted diseases
- Section 10 Environmental medicine, occupational medicine, and poisoning
- Section 11 Nutrition
- Section 12 Metabolic disorders
- Section 13 Endocrine disorders
- 13.1 Principles of hormone action
- 13.2 Pituitary disorders
- 13.3 Thyroid disorders
- 13.4 Parathyroid disorders and diseases altering calcium metabolism
- 13.5 Adrenal disorders
- 13.6 Reproductive disorders
- 13.6.1 Ovarian disorders
- 13.6.2 Disorders of male reproduction and male hypogonadism
- 13.6.3 Benign breast disease
- 13.6.4 Sexual dysfunction
- 13.7 Disorders of growth and development
- 13.8 Pancreatic endocrine disorders and multiple endocrine neoplasia
- 13.9 Diabetes and hypoglycaemia
- 13.10 Hormonal manifestations of nonendocrine disease
- 13.11 The pineal gland and melatonin
- Section 14 Medical disorders in pregnancy
- Section 15 Gastroenterological disorders
- Section 16 Cardiovascular disorders
- Section 17 Critical care medicine
- Section 18 Respiratory disorders
- Section 19 Rheumatological disorders
- Section 20 Disorders of the skeleton
- Section 21 Disorders of the kidney and urinary tract
- Section 22 Haematological disorders
- Section 23 Disorders of the skin
- Section 24 Neurological disorders
- Section 25 Disorders of the eye
- Section 26 Psychiatric and drug-related disorders
- Section 27 Forensic medicine
- Section 28 Sport and exercise medicine
- Section 29 Biochemistry in medicine
- Section 30 Acute medicine
Sexual dysfunction
- Chapter:
- Sexual dysfunction
- Author(s):
Ian Eardley
- DOI:
- 10.1093/med/9780198746690.003.0254
Male sexual dysfunction is common, with the most common types being erectile dysfunction, premature ejaculation, penile deformity, and priapism. Erectile dysfunction is common, becomes commoner with increasing age, and is often associated with cardiovascular disease and its risk factors. Patient assessment should seek to identify causative risk factors and treatment in the first instance is usually the management of risk factors and oral pharmacotherapy with a phosphodiesterase type 5 inhibitor. In women, sexual desire disorders are commoner in older postmenopausal women and a new treatment, flibanserin, has recently been licensed for this indication. Sexual arousal disorders in women also become more common postmenopausally and have a multifactorial aetiology. Treatment should be directed at the aetiological factor in the first instance while trials of oral pharmacotherapy for this condition have been disappointing.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Section 1 Patients and their treatment
- Section 2 Background to medicine
- Section 3 Cell biology
- Section 4 Immunological mechanisms
- Section 5 Principles of clinical oncology
- Section 6 Old age medicine
- Section 7 Pain and palliative care
- Section 8 Infectious diseases
- Section 9 Sexually transmitted diseases
- Section 10 Environmental medicine, occupational medicine, and poisoning
- Section 11 Nutrition
- Section 12 Metabolic disorders
- Section 13 Endocrine disorders
- 13.1 Principles of hormone action
- 13.2 Pituitary disorders
- 13.3 Thyroid disorders
- 13.4 Parathyroid disorders and diseases altering calcium metabolism
- 13.5 Adrenal disorders
- 13.6 Reproductive disorders
- 13.6.1 Ovarian disorders
- 13.6.2 Disorders of male reproduction and male hypogonadism
- 13.6.3 Benign breast disease
- 13.6.4 Sexual dysfunction
- 13.7 Disorders of growth and development
- 13.8 Pancreatic endocrine disorders and multiple endocrine neoplasia
- 13.9 Diabetes and hypoglycaemia
- 13.10 Hormonal manifestations of nonendocrine disease
- 13.11 The pineal gland and melatonin
- Section 14 Medical disorders in pregnancy
- Section 15 Gastroenterological disorders
- Section 16 Cardiovascular disorders
- Section 17 Critical care medicine
- Section 18 Respiratory disorders
- Section 19 Rheumatological disorders
- Section 20 Disorders of the skeleton
- Section 21 Disorders of the kidney and urinary tract
- Section 22 Haematological disorders
- Section 23 Disorders of the skin
- Section 24 Neurological disorders
- Section 25 Disorders of the eye
- Section 26 Psychiatric and drug-related disorders
- Section 27 Forensic medicine
- Section 28 Sport and exercise medicine
- Section 29 Biochemistry in medicine
- Section 30 Acute medicine